IP Verse

Treatment Of Cancer Using Anti-Cd19 Chimeric Antigen Receptor - EP3888674

The patent EP3888674 was granted to Novartis on Apr 3, 2024. The application was originally filed on Apr 7, 2015 under application number EP21160203A. The patent is currently recorded with a legal status of "Revoked".

EP3888674

NOVARTIS
Application Number
EP21160203A
Filing Date
Apr 7, 2015
Status
Revoked
Aug 22, 2025
Grant Date
Apr 3, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

J A KEMPJan 3, 2025J A KEMPADMISSIBLE

Patent Citations (159) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0090505
DESCRIPTIONEP0239400
DESCRIPTIONEP0519596
DESCRIPTIONEP0592106
DESCRIPTIONEP1866339
DESCRIPTIONEP1947183
DESCRIPTIONFR901228
DESCRIPTIONUS2004040047
DESCRIPTIONUS2004047858
DESCRIPTIONUS2004101519
DESCRIPTIONUS2005042664
DESCRIPTIONUS2005048617
DESCRIPTIONUS2005100543
DESCRIPTIONUS2005101624
DESCRIPTIONUS2005175606
DESCRIPTIONUS2006034810
DESCRIPTIONUS2006121005
DESCRIPTIONUS2007014794
DESCRIPTIONUS2007036773
DESCRIPTIONUS2009082299
DESCRIPTIONUS2010028330
DESCRIPTIONUS2010247521
DESCRIPTIONUS2011081311
DESCRIPTIONUS2011158957
DESCRIPTIONUS2011286980
DESCRIPTIONUS2012039906
DESCRIPTIONUS2012060230
DESCRIPTIONUS2012114649
DESCRIPTIONUS2012141413
DESCRIPTIONUS2012177598
DESCRIPTIONUS2012321667
DESCRIPTIONUS2013156774
DESCRIPTIONUS2014068797
DESCRIPTIONUS2014255360
DESCRIPTIONUS2014271618
DESCRIPTIONUS3929992
DESCRIPTIONUS44768
DESCRIPTIONUS4816567
DESCRIPTIONUS5199942
DESCRIPTIONUS5225539
DESCRIPTIONUS5350674
DESCRIPTIONUS5399346
DESCRIPTIONUS5530101
DESCRIPTIONUS5565332
DESCRIPTIONUS5580859
DESCRIPTIONUS5585089
DESCRIPTIONUS5585362
DESCRIPTIONUS5589466
DESCRIPTIONUS5665772
DESCRIPTIONUS5766886
DESCRIPTIONUS5786464
DESCRIPTIONUS5858358
DESCRIPTIONUS5883223
DESCRIPTIONUS6004973
DESCRIPTIONUS6015815
DESCRIPTIONUS6111090
DESCRIPTIONUS6114148
DESCRIPTIONUS6120766
DESCRIPTIONUS6326193
DESCRIPTIONUS6331415
DESCRIPTIONUS6352694
DESCRIPTIONUS6407213
DESCRIPTIONUS6534055
DESCRIPTIONUS6548640
DESCRIPTIONUS6692964
DESCRIPTIONUS6703199
DESCRIPTIONUS6797514
DESCRIPTIONUS6867041
DESCRIPTIONUS6887466
DESCRIPTIONUS6905680
DESCRIPTIONUS6905681
DESCRIPTIONUS6905874
DESCRIPTIONUS7025962
DESCRIPTIONUS7067318
DESCRIPTIONUS7091213
DESCRIPTIONUS7132255
DESCRIPTIONUS7144575
DESCRIPTIONUS7172869
DESCRIPTIONUS7175843
DESCRIPTIONUS7232566
DESCRIPTIONUS7618632
DESCRIPTIONUS7727950
DESCRIPTIONUS7812135
DESCRIPTIONUS7943743
DESCRIPTIONUS8008449
DESCRIPTIONUS8124084
DESCRIPTIONUS8354509
DESCRIPTIONUS8388967
DESCRIPTIONUS8586023
DESCRIPTIONUS8591886
DESCRIPTIONUS8609089
DESCRIPTIONUS8697359
DESCRIPTIONUS8771945
DESCRIPTIONUS8795965
DESCRIPTIONUS8865406
DESCRIPTIONUS8871445
DESCRIPTIONWO0103720
DESCRIPTIONWO0129058
DESCRIPTIONWO0196584
DESCRIPTIONWO2005007190
DESCRIPTIONWO2005055808
DESCRIPTIONWO2005115451
DESCRIPTIONWO2006020258
DESCRIPTIONWO2006083289
DESCRIPTIONWO2006121168
DESCRIPTIONWO2006122806
DESCRIPTIONWO2007005874
DESCRIPTIONWO2007024715
DESCRIPTIONWO2007044729
DESCRIPTIONWO2007133822
DESCRIPTIONWO2009101611
DESCRIPTIONWO2009104019
DESCRIPTIONWO2009114335
DESCRIPTIONWO2010003118
DESCRIPTIONWO2010019570
DESCRIPTIONWO2010027827
DESCRIPTIONWO2010051043
DESCRIPTIONWO2010077634
DESCRIPTIONWO2010114484
DESCRIPTIONWO2010125571
DESCRIPTIONWO2011028683
DESCRIPTIONWO2011051726
DESCRIPTIONWO2011066342
DESCRIPTIONWO2011090754
DESCRIPTIONWO2012006552
DESCRIPTIONWO2012007926
DESCRIPTIONWO2012079000
DESCRIPTIONWO2012138475
DESCRIPTIONWO2013006490
DESCRIPTIONWO2013023184
DESCRIPTIONWO2013039954
DESCRIPTIONWO2013054331
DESCRIPTIONWO2013082366
DESCRIPTIONWO2013126712
DESCRIPTIONWO2014022332
DESCRIPTIONWO2014055442
DESCRIPTIONWO2014055657
DESCRIPTIONWO2014059251
DESCRIPTIONWO2014110591
DESCRIPTIONWO2014127261
DESCRIPTIONWO2014151960
DESCRIPTIONWO2014153270
DESCRIPTIONWO2014164348
DESCRIPTIONWO2014197638
DESCRIPTIONWO9109967
DESCRIPTIONWO9317105
DESCRIPTIONWO9409010
DESCRIPTIONWO9514023
DESCRIPTIONWO9516691
DESCRIPTIONWO9641807
DESCRIPTIONWO9731899
DESCRIPTIONWO9802441
DESCRIPTIONWO9915530
DESCRIPTIONWO9920758
DESCRIPTIONWO9940196
DESCRIPTIONWO9952552
OPPOSITIONWO2015142675
SEARCHWO2012079000
SEARCHWO2014153270

Non-Patent Literature (NPL) Citations (189) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- ACS Med. Chem. Lett., (20100000), vol. 1, pages 39 - 43
DESCRIPTION- ADVANI et al., J Clin Oncol, (20120000), vol. 31, page 88
DESCRIPTION- ADVANI et al., J. Clin. Oncol., (20130000), vol. 31, page 88
DESCRIPTION- AGATA et al., Int. Immunol, (19960000), vol. 8, pages 765 - 75
DESCRIPTION- AL-LAZIKANI et al., JMB, (19970000), vol. 273, pages 927 - 948
DESCRIPTION- ALTSCHUL et al., J. Mol. Biol., (19900000), vol. 215, pages 403 - 410
DESCRIPTION- ALTSCHUL et al., Nuc. Acids Res., (19770000), vol. 25, pages 3389 - 3402
DESCRIPTION- ARONOVICH et al., Hum. Mol. Genet., (20110000), vol. 20, no. R1, pages R14 - 20
DESCRIPTION- BACA et al., J. Biol. Chem., (19970000), vol. 272, no. 16, pages 10678 - 84
DESCRIPTION- BARRANGOU et al., Science, (20070000), vol. 315, pages 1709 - 1712
DESCRIPTION- BARRETT et al., Human Gene Therapy, (20110000), vol. 22, pages 1575 - 1586
DESCRIPTION- BATZER et al., Nucleic Acid Res, (19910000), vol. 19, page 5081
DESCRIPTION- BELL et al., Nat. Protoc., (20070000), vol. 2, no. 12, pages 3153 - 65
DESCRIPTION- BENJAMINI, Y et al., J. Roy. Statist., (19950000), vol. 57, pages 289 - 300
DESCRIPTION- BERG et al., Transplant Proc, (19980000), vol. 30, no. 8, pages 3975 - 3977
DESCRIPTION- BIERER et al., Curr. Opin. Immun., (19930000), vol. 5, pages 763 - 773
DESCRIPTION- BITINAITE et al., Proc. Natl. Acad. Sci. USA, (19980000), vol. 95, pages 10570 - 5
DESCRIPTION- BLANK et al., Cancer Immunol. Immunother, (20050000), vol. 54, pages 307 - 314
DESCRIPTION- BORASCHI, D et al., Sci. Transl. Med., (20130000), vol. 5
DESCRIPTION- BOULAY et al., Cancer Res, (20040000), vol. 64, pages 252 - 61
DESCRIPTION- CALDAS et al., Protein Eng., (20000000), vol. 13, no. 5, pages 353 - 60
DESCRIPTION- CARROLL et al., Genetics Society of America, (20110000), vol. 188, pages 773 - 782
DESCRIPTION- CARTER et al., Eur J Immunol, (20020000), vol. 32, pages 634 - 43
DESCRIPTION- CARTER et al., Proc. Natl. Acad. Sci. USA, (19920000), vol. 89, page 4285
DESCRIPTION- CAS, no. 951209-71-5
DESCRIPTION- CASULO et al., Clin Immunol, (20140000), vol. 154, no. 1, pages 37 - 46
DESCRIPTION- CATHOMEN et al., Mol. Ther., (20080000), vol. 16, pages 1200 - 589
DESCRIPTION- CERMAK et al., Nucl. Acids Res., (20110000), vol. 39, page e82
DESCRIPTION- CHEN, C et al., Sci. Signal., (20090000), vol. 2, page 75
DESCRIPTION- CHEN, J.ZHENG, X. F.BROWN, E. J.SCHREIBER, S. L., "Identification of an 11-kDa FKBP 12-rapamycin-binding domain within the 289-kDa FKBP 12rapamycin-associated protein and characterization of a critical serine residue", Proc Natl Acad Sci USA, (19950000), vol. 92, pages 4947 - 51
DESCRIPTION- CHESON et al., J Clin Oncol, (19990000), vol. 17, page 1244
DESCRIPTION- CHESON et al., "Revised Response Criteria for Malignant Lymphoma", J Clin Oncol, (20070000), vol. 25, pages 579 - 586
DESCRIPTION- CHOTHIA et al., J. Mol. Biol., (19870000), vol. 196, page 901
DESCRIPTION- CHRESTA, C.M. et al., Cancer Res, (20100000), vol. 70, no. 1, pages 288 - 298
DESCRIPTION- COUGOT et al., Trends in Biochem. Sci., (20010000), vol. 29, pages 436 - 444
DESCRIPTION- COUTO et al., Cancer Res., (19950000), vol. 55, no. 8, pages 5973s - 5977s
DESCRIPTION- CRUZ et al., Cytotherapy, (20100000), vol. 12, no. 6, pages 743 - 749
DESCRIPTION- "Current and Future Treatment Strategies for Patients with Advanced Hepatocellular Carcinoma: Role of mTOR Inhibition. Finn RS", Liver Cancer, (20121100), vol. l, no. 3-4, pages 247 - 256
DESCRIPTION- DE VISSER et al., Cancer Cell, (20050000), vol. 7, no. 5, pages 411 - 23
DESCRIPTION- DING et al., Cell, (20050000), vol. 122, no. 3, pages 473 - 83
DESCRIPTION- DI STASA et al., N Engl. J. Med., (20111103), vol. 365, no. 18, pages 1673 - 1683
DESCRIPTION- DONG et al., J Mol Med, (20030000), vol. 81, pages 281 - 7
DESCRIPTION- DOYON et al., Nature Methods, (20100000), vol. 8, pages 74 - 79
DESCRIPTION- DUBOVKSY et al., Blood, (20130000), vol. 122, no. 15, pages 2539 - 1349
DESCRIPTION- DURIE et al., Leukemia, (20060000), vol. 20, no. 9, pages 1467 - 1473
DESCRIPTION- ELANGO et al., Biochim. Biophys. Res. Commun., (20050000), vol. 330, pages 958 - 966
DESCRIPTION- E. MEYERSW. MILLER, Comput. Appl. Biosci., (19880000), vol. 4, pages 11 - 17
DESCRIPTION- FLYNN, JM et al., Aging Cell, (20130000), vol. 12, pages 851 - 862
DESCRIPTION- FORERO-TORRES et al., Clin Cancer Res, (20120000), vol. 18, no. 5, pages 1395 - 403
DESCRIPTION- FREEMAN et al., J Exp Med, (20000000), vol. 192, pages 1027 - 34
DESCRIPTION- GARCIA-MARTINEZ JM et al., Biochem J., (20090000), vol. 421, no. 1, pages 29 - 42
DESCRIPTION- GARLAND et al., J. Immunol Meth., (19990000), vol. 227, no. 1-2, pages 53 - 63
DESCRIPTION- GEIBLER et al., PLoS ONE, (20110000), vol. 6, page e19509
DESCRIPTION- "GenBank", Database accession no. AAC51724.1
DESCRIPTION- GHOSH et al., Glycobiology, (19910000), vol. 5, pages 505 - 10
DESCRIPTION- GOLDENBERG et al., Leuk Lymphoma, (20100000), vol. 51, no. 5, pages 747 - 55
DESCRIPTION- GRABUNDZIJA et al., Mol. Ther., (20100000), vol. 18, pages 1200 - 1209
DESCRIPTION- GRABUNDZIJA et al., Nucleic Acids Res, (20130000), vol. 41, no. 3, pages 1829 - 47
DESCRIPTION- GRISSA et al., BMC Bioinformatics, (20070000), vol. 8, page 172
DESCRIPTION- GRUPP et al., NEJM, (20130000), vol. 369, no. 1, pages 1509 - 1518
DESCRIPTION- GUO et al., J. Mol. Biol., (20100000), vol. 400, page 96
DESCRIPTION- HAANEN et al., J. Exp. Med., (19990000), vol. 190, no. 9, page 13191328
DESCRIPTION- HAFT et al., PLoS Comput. Biol., (20050000), vol. 1, page e60
DESCRIPTION- HARRISON, DE et al., Nature, (20090000), vol. 460, pages 392 - 395
DESCRIPTION- HENDERSON et al., Immun, (19910000), vol. 73, pages 316 - 321
DESCRIPTION- HOCKEMEYER et al., Nature Biotech, (20110000), vol. 29, pages 149 - 734
DESCRIPTION- HOLLINGER et al., Proc Natl Acad. Sci. U.S.A., (19930000), vol. 90, pages 6444 - 6448
DESCRIPTION- HOLLINGERHUDSON, Nature Biotechnology, (20050000), vol. 23, pages 1126 - 1136
DESCRIPTION- HONIGBERG et al., Proc. Natl. Acad. Sci. USA., (20100000), vol. 107, pages 13075 - 80
DESCRIPTION- HORVATH et al., Science, (20100000), vol. 327, pages 167 - 170
DESCRIPTION- HOUSTON et al., Proc. Natl. Acad. Sci. USA, (19880000), vol. 85, pages 5879 - 5883
DESCRIPTION- IZUMOTO et al., J Neurosurg, (20080000), vol. 108, pages 963 - 971
DESCRIPTION- JONES et al., Blood, (20090000), vol. 113, no. 23, pages 5920 - 5926
DESCRIPTION- JONES et al., Nature, (19860000), vol. 321, pages 522 - 525
DESCRIPTION- JUNE et al., Nature Reviews Immunology, (20090000), vol. 9, no. 10, pages 704 - 716
DESCRIPTION- KALOS et al., Science Translational Medicine, (20110000), vol. 3, no. 95, pages 95 - 73
DESCRIPTION- KALOS M et al., Sci Transl Med, (20110000), vol. 3, pages 95 - 73
DESCRIPTION- KAPPOS et al., Lancet, (20110000), vol. 19, no. 378, pages 1779 - 87
DESCRIPTION- KENDAL, AP et al., Concepts and procedures for laboratory-based influenza surveillance, Centers for Disease Control and Prevention, (19820000), vol. B17-B35
DESCRIPTION- KIM et al., J Immunotherapy, (20080000), vol. 31, no. 5, pages 446 - 57
DESCRIPTION- KIM et al., Proc. Natl. Acad. Sci. USA, (19960000), vol. 93, pages 1156 - 1160
DESCRIPTION- KONISHI et al., Clin Cancer Res, (20040000), vol. 10, page 5094
DESCRIPTION- KUNIN et al., Genome Biol, (20070000), vol. 8, page R61
DESCRIPTION- LAGES, CS et al., Aging Cell, (20100000), vol. 9, pages 785 - 798
DESCRIPTION- LANZAVECCHIA et al., Eur. J. Immunol., (19870000), vol. 17, page 105
DESCRIPTION- LATCHMAN et al., Nat Immunol, (20010000), vol. 2, pages 261 - 8
DESCRIPTION- LIM et al., Haematologica, (20100000), vol. 95, no. 1, pages 135 - 43
DESCRIPTION- LIU et al., Cell, (19910000), vol. 66, pages 807 - 815
DESCRIPTION- MAECKER, HT et al., Nat Rev Immunol, (20120000), vol. 12, pages 191 - 200
DESCRIPTION- MAKAROVA et al., Biology Direct, (20060000), vol. 1, page 7
DESCRIPTION- MARKEL et al., Cancer Immunol Immunother, (20100200), vol. 59, no. 2, pages 215 - 30
DESCRIPTION- MARKEL et al., Immunology, (20090200), vol. 126, no. 2, pages 186 - 200
DESCRIPTION- MARKEL et al., J Immunol, (20020315), vol. 168, no. 6, pages 2803 - 10
DESCRIPTION- MARKEL et al., J Immunol, (20061101), vol. 177, no. 9, pages 6062 - 71
DESCRIPTION- MARRAGINI et al., Science, (20080000), vol. 321, pages 1843 - 1845
DESCRIPTION- MARZEC M et al., Blood, (20060000), vol. 108, pages 1744 - 1750
DESCRIPTION- MARZEC M et al., Blood, (20080000), vol. 111, pages 2181 - 2189
DESCRIPTION- MARZEC M et al., PLoS One, vol. 6, page e24849
DESCRIPTION- MCALPINE, J.B. et al., J. Antibiotics, (19910000), vol. 44, page 688
DESCRIPTION- MILONE et al., Molecular Therapy, (20090000), vol. 17, no. 8, pages 1453 - 1464
DESCRIPTION- MILONE et al., Molecular Therapy: the Journal of the American Society of Gene Therapy, (20090000), vol. 17, no. 8, pages 1453 - 64
DESCRIPTION- MILONE et al., Mol. Ther., (20090000), vol. 17, no. 8, pages 1453 - 1464
DESCRIPTION- MOEINI ACORNELLA HVILLANUEVA A, "Emerging Signaling Pathways in Hepatocellular Carcinoma", Liver Cancer, (20120900), vol. l, no. 2, pages 83 - 93
DESCRIPTION- MOJICA et al., J. Mol. Evol., (20050000), vol. 60, pages 174 - 182
DESCRIPTION- MONNEY et al., Nature, (20020000), vol. 415, pages 536 - 541
DESCRIPTION- MOREA et al., Methods, (20000000), vol. 20, no. 3, pages 267 - 79
DESCRIPTION- MOSCOU et al., Science, (20090000), vol. 326, pages 3501 - 12
DESCRIPTION- NACHEVABERZAL-HERRANZ, Eur. J. Biochem., (20030000), vol. 270, pages 1485 - 65
DESCRIPTION- "NCBI", Database accession no. NM_000734.3
DESCRIPTION- NEEDLEMANWUNSCH, J. Mol. Biol., (19700000), vol. 48, pages 444 - 453
DESCRIPTION- NGIOW et al., Cancer Res, (20110000), vol. 71, pages 3540 - 3551
DESCRIPTION- NICHOLSON et al., Mol. Immun., (19970000), vol. 34, no. 16-17, pages 1157 - 1165
DESCRIPTION- NISHIKAWA et al., Hum Gene Ther., (20010000), vol. 12, no. 8, pages 861 - 70
DESCRIPTION- OHTSUKA et al., J. Biol. Chem., (19850000), vol. 260, pages 2605 - 2608
DESCRIPTION- ORTENBERG et al., Mol Cancer Ther, (20120600), vol. ll, no. 6, pages 1300 - 10
DESCRIPTION- PADLAN, Molecular Immunology, (19910000), vol. 28, no. 4,5, pages 489 - 498
DESCRIPTION- PARIKH et al., Blood, (20140000), vol. 123, no. 15, pages 2343 - 54
DESCRIPTION- PEARSONLIPMAN, Proc. Nat'l. Acad. Sci. USA, (19880000), vol. 85, page 2444
DESCRIPTION- PEDERSEN et al., J. Mol. Biol., (19940000), vol. 235, no. 3, pages 959 - 73
DESCRIPTION- PENNISI, Science, (20130000), vol. 339, pages 819 - 823
DESCRIPTION- PONADER et al., Blood, (20120000), vol. 119, no. 18, pages 4123 - 487
DESCRIPTION- PORTER DL et al., N Engl J Med, (20110000), vol. 365, pages 725 - 733
DESCRIPTION- PORTER et al., NEJM, (20110000), vol. 365, pages 725 - 733
DESCRIPTION- POURCEL et al., Microbiol, (20050000), vol. 151, pages 2551 - 2561
DESCRIPTION- PRESTA, Curr. Op. Struct. Biol., (19920000), vol. 2, pages 593 - 596
DESCRIPTION- PRESTA et al., J. Immunol., (19930000), vol. 151, page 2623
DESCRIPTION- PROVASI, Nature Med, (20110000), vol. 18, pages 807 - 815
DESCRIPTION- PYONTECK et al., Nat. Med., (20130000), vol. 19, pages 1264 - 72
DESCRIPTION- RIECHMANN et al., Nature, (19880000), vol. 332, pages 323 - 327
DESCRIPTION- ROBAK, Curr. Opin. Investig. Drugs., (20090000), vol. 10, no. 6, pages 588 - 96
DESCRIPTION- ROBAK et al., BioDrugs, (20110000), vol. 25, no. 1, pages 13 - 25
DESCRIPTION- ROGUSKA et al., PNAS, (19940000), vol. 91, pages 969 - 973
DESCRIPTION- ROGUSKA et al., Protein Eng., (19960000), vol. 9, no. 10, pages 895 - 904
DESCRIPTION- ROSENBERG et al., New Eng. J. of Med., (19880000), vol. 319, page 1676
DESCRIPTION- ROSSOLINI et al., Mol. Cell. Probes, (19940000), vol. 8, pages 91 - 98
DESCRIPTION- RUELLA et al., Expert Opin. Biol. Ther., (20150000), pages 1 - 6
DESCRIPTION- SADELAIN et al., Cancer Discovery, (20130000), vol. 3, pages 388 - 398
DESCRIPTION- SAGIV-BARFI et al., "Ibrutinib enhances the antitumor immune response induced by intratumoral injection of a TLR9 ligand in syngeneic mouse lymphoma model", Blood, (20150206), page 593137
DESCRIPTION- SALVADORI M, "Antineoplastic effects of mammalian target of rapamycine inhibitors", World J Transplant, (20121024), vol. 2, no. 5, pages 74 - 83
DESCRIPTION- SANDHU J S, Gene, (19940000), vol. 150, no. 2, pages 409 - 10
DESCRIPTION- SCHENBORNMIERENDORF, Nuc Acids Res., (19850000), vol. 13, pages 6223 - 36
DESCRIPTION- SCHREIBER, S.L. et al., J. Am. Chem. Soc., (19910000), vol. 113, page 7433
DESCRIPTION- SHIMATANI, K et al., Proc. Natl. Acad. Sci. USA, (20090000), vol. 106, pages 15807 - 15812
DESCRIPTION- SINGH et al., Cancer Res, (20080000), vol. 68, no. 8, pages 2961 - 2971
DESCRIPTION- SPENSIERI, F et al., Proc. Natl. Acad. Sci. USA, (20130000), vol. 110, pages 14330 - 14335
DESCRIPTION- STEPHAN et al., Nature Biotechnology, (20150000), vol. 33, pages 97 - 101
DESCRIPTION- STEPINSKI et al., RNA, (20010000), vol. 7, pages 1468 - 95
DESCRIPTION- STERN et al., J Immunol, (20050601), vol. 174, no. 11, pages 6692 - 701
DESCRIPTION- STERN et al., Trends. Genet., (20100000), vol. 28, pages 335 - 340
DESCRIPTION- STUDNICKA et al., Protein Engineering, (19940000), vol. 7, no. 6, pages 805 - 814
DESCRIPTION- SUN, L et al., Genet. Epidemiol., (20060000), vol. 30, pages 519 - 530
DESCRIPTION- SZCZEPEK et al., Nature Biotech, (20070000), vol. 25, pages 786 - 793
DESCRIPTION- TAN et al., J. Immunol., (20020000), vol. 169, pages 1119 - 25
DESCRIPTION- TOBIAS MAETZIG et al., "Gammaretroviral Vectors: Biology, Technology and Application", Viruses, (20110600), vol. 3, no. 6, pages 677 - 713
DESCRIPTION- TSAI, Nature Biotechnol., (20140000), vol. 32, no. 6, pages 569 - 576
DESCRIPTION- UI-TEI et al., FEBS Letters, (20000000), vol. 479, pages 79 - 82
DESCRIPTION- "UniProt", Database accession no. P15391
DESCRIPTION- VENKATESAN, A.M., J. Med.Chem., (20100000), vol. 53, pages 2636 - 2645
DESCRIPTION- VERHOEYEN et al., Science, (19880000), vol. 239, pages 1534 - 1536
DESCRIPTION- WIEDENHEFT et al., Nature, (20120000), vol. 1 -4, pages 331 - 8
DESCRIPTION- WILKINSON JE et al., Aging Cell, (20120000), vol. 11, pages 675 - 682
DESCRIPTION- WILLIAMS, Molecular Therapy, (20080000), vol. 16, no. 9, pages 1515 - 16
DESCRIPTION- WITZIG TE et al., Hematology Am Soc Hematol Educ Program, (20100000), pages 265 - 270
DESCRIPTION- WOOD et al., Science, (20110000), vol. 333, page 307
DESCRIPTION- WOYACH et al., NEJM, (20140000), vol. 371, no. 16, pages 1507 - 17
DESCRIPTION- ZHANG Q et al., Proc Natl Acad Sci USA, (20110000), vol. 108, pages 11977 - 11982
DESCRIPTION- ZHENG et al., PLoS One, (20100902), vol. 5, no. 9, page e12529
DESCRIPTION- MEYERSON et al., "hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization", Cell, (19970822), vol. 90, doi:10.1016/S0092-8674(00)80538-3, pages 785 - 795, XP002056804
DESCRIPTION- YU K et al., "Biochemical, Cellular, and In vivo Activity of Novel ATP-Competitive and Selective Inhibitors of the Mammalian Target of Rapamycin", Cancer Res, (20090000), vol. 69, no. 15, doi:10.1158/0008-5472.CAN-09-0299, pages 6232 - 6240, XP008132305
DESCRIPTION- CARL JUNE, "Adoptive T cell therapy for cancer in the clinic", Journal of Clinical Investigation, (20070000), vol. 117, doi:10.1172/JCI32446, pages 1466 - 1476, XP055287551
DESCRIPTION- MARZEC et al., "Mantle cell lymphoma cells express predominantly cyclin Dla isoform and are highly sensitive to selective inhibition of CDK4 kinase activity", Blood, (20060511), vol. 108, no. 5, doi:10.1182/blood-2006-04-016634, pages 1744 - 50, XP055578941
OPPOSITION- Anonymous, "IMBRUVICA TM (ibrutinib) capsules, for oral use - HIGHLIGHTS OF PRESCRIBING INFORMATION", FDA, FDA, URL: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205552Orig2lbl.pdf, XP093252922
OPPOSITION- Cammack, Richard ; Attwood, Teresa K., "Passage", Cammack, Richard ; Attwood, Teresa K., R. Cammack et al., Oxford Dictionary of Biochemistry and Molecular Biology (2 ed.), Oxford University Press, (20060101), page 95, ISBN 9780198529170, XP009559635
OPPOSITION- David L Porter, Frey Noelle V; Melenhorst J Joseph; Hwang Wei-Ting; Lacey Simon F; Shaw Pamela; Chew Anne; Grupp Stephan A; Capobianchi James; Gilmore Joan; Kalos Michael; Litchman Manuel; Lledo Lester; Loren Alison Wakoff; Mahnke Yolanda; Marcucci Katherine T; Mcconville Holly; Shen Angela; Wood Patricia A; Zheng Zhaohui; Levine Bruce L; June Carl H, "Randomized, Phase II Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019) in Patients with Relapsed, Refractory CLL", Blood, W.B. Saunders, AMSTERDAM, NL, AMSTERDAM, NL, (20141206), vol. 124, no. 21, ISSN 0006-4971, pages 1982 - 1982, XP055476042
OPPOSITION- Mazzarella Luca, "Tales from the Jazz ASH: highlights from the 2013 American Society of Haematology meeting ", ecancermedicalscience, Cancer Intelligence, (20140124), ISSN 1754-6605, XP093252926
OPPOSITION- Ahmad Ubaid, Khan Zafran, Ualiyeva Daniya, Amissah Obed Boadi, Noor Zohaib, Khan Asaf, Zaman Nasib, Khan Marwa, Khan Ayub, Ali Babar, "Chimeric antigen receptor T cell structure, its manufacturing, and related toxicities; A comprehensive review", Advances in Cancer Biology - Metastasis, (20220701), vol. 4, doi:10.1016/j.adcanc.2022.100035, ISSN 2667-3940, page 100035, XP093063040
OPPOSITION- S C H Karlsson, A C Lindqvist, M Fransson, G Paul-Wetterberg, B Nilsson, M Essand, K Nilsson, P Frisk, H Jernberg-Wiklund, S I A Loskog, "Combining CAR T cells and the Bcl-2 family apoptosis inhibitor ABT-737 for treating B-cell malignancy", Cancer Gene Therapy, Nature Publishing Group US, New York, New York, (20130701), vol. 20, no. 7, doi:10.1038/cgt.2013.35, ISSN 0929-1903, pages 386 - 393, XP055403655
OPPOSITION- Heslop Helen E, "Combining Drugs and Biologics to Treat Nasopharyngeal Cancer", Molecular Therapy, (20140101), vol. 22, no. 1, doi:10.1038/mt.2013.272, ISSN 1525-0016, pages 8 - 9, XP093252930
OPPOSITION- P Viatour, M Bentires-Alj, A Chariot, V Deregowski, L De Leval, M-P Merville, V Bours, "NF-&kgr;B2/p100 induces Bcl-2 expression", Leukemia, Stockton Press, (20030701), vol. 17, no. 7, doi:10.1038/sj.leu.2402982, ISSN 08876924, pages 1349 - 1356, XP055184360
OPPOSITION- John C. Byrd, Richard R. Furman, Steven E. Coutre, Ian W. Flinn, Jan A. Burger, Kristie A. Blum, Barbara Grant, Jeff P. Sharman, Morton Coleman, William G. Wierda, Jeffrey A. Jones, Weiqiang Zhao, Nyla A. Heerema, Amy J. Johnson, Juthamas Sukbuntherng, Betty Y. Chang, Fong Clow, Eric Hedrick, Joseph J. Buggy, Danelle F. James, Susan O'brien, "Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia", The New England journal of medicine, Massachusetts Medical Society, US, US , (20130704), vol. 369, no. 1, doi:10.1056/NEJMoa1215637, ISSN 0028-4793, pages 32 - 42, XP055233941
OPPOSITION- Awan Farrukh T., Byrd John C., "New Strategies in Chronic Lymphocytic Leukemia: Shifting Treatment Paradigms", Cancer Research, Association for Cancer Research, US, US, (20141201), vol. 20, no. 23, doi:10.1158/1078-0432.CCR-14-1889, ISSN 1078-0432, pages 5869 - 5874, XP093252929
OPPOSITION- M. F. M. De Rooij, A. Kuil, C. R. Geest, E. Eldering, B. Y. Chang, J. J. Buggy, S. T. Pals, M. Spaargaren, "The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia", Blood, W.B. Saunders, AMSTERDAM, NL, AMSTERDAM, NL, (20120315), vol. 119, no. 11, doi:10.1182/blood-2011-11-390989, ISSN 0006-4971, pages 2590 - 2594, XP055355469
OPPOSITION- J. A. Dubovsky, K. A. Beckwith, G. Natarajan, J. A. Woyach, S. Jaglowski, Y. Zhong, J. D. Hessler, T.-M. Liu, B. Y. Chang, K. M. Larkin, M. R. Stefanovski, D. L. Chappell, F. W. Frissora, L. L. Smith, K. A. Smucker, J. M. Flynn, J. A. Jones, L. A. Andritsos, K. Maddocks, A. M. Lehman, R. Furman, J. Sharman, A. Mishra, M. A. Caligiuri, A. R. Satoskar, J. J. Buggy, N. Muthusamy, A. J. Johnson, J. C. Byrd, "Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes", Blood, (20131010), vol. 122, no. 15, doi:10.1182/blood-2013-06-507947, ISSN 00064971, pages 2539 - 2549, XP055213911
OPPOSITION- Porter David L.; Kalos Michael; Frey Noelle V.; Grupp Stephan A; Loren Alison W.; Jemision Christina; Gilmore Joan; McConville Holly; Capobianchi James; Lledo Lester; Chew Anne; Shen Angela; Wood Patricia A.; Litchman Manuel; Zheng Zhaohui; Levine Bruce L.; June Carl H., "Randomized, Phase II Dose Optimization Study Of Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019) In Patients With Relapsed, Refractory CLL", Blood, W.B. Saunders, AMSTERDAM, NL, AMSTERDAM, NL, (20131115), vol. 122, no. 21, doi:10.1182/blood.V122.21.873.873, ISSN 0006-4971, page 873, XP086750925
OPPOSITION- Zhang Wei; Stevens Brett M; Budde Elizabeth Elizabeth; Forman Stephen J.; Jordan Craig T.; Purev Enkhtsetseg, "Anti-CD123 CAR T-Cell Therapy for the Treatment of Myelodysplastic Syndrome", Blood, W.B. Saunders, AMSTERDAM, NL, AMSTERDAM, NL, (20171208), vol. 130, doi:10.1182/blood.V130.Suppl_1.1917.1917, ISSN 0006-4971, page 1917, XP086631770
OPPOSITION- Oh Bernice L.Z., Vinanica Natasha, Wong Desmond M.H., Campana Dario, "Chimeric antigen receptor T-cell therapy for T-cell acute lymphoblastic leukemia", Haematologica, vol. 109, no. 6, doi:10.3324/haematol.2023.283848, ISSN 0390-6078, pages 1677 - 1688, XP093252933
SEARCH- HUYE E L ET AL, "Combining mTor Inhibitors With Rapamycin-resistant T Cells: A Two-pronged Approach to Tumor Elimination", MOLECULAR THERAPY, GB, (20110830), vol. 19, no. 12, doi:10.1038/mt.2011.179, ISSN 1525-0016, pages 2239 - 2248, XP055191016 [A] 1-14 * the whole document *
SEARCH- XU Y ET AL, "Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15", BLOOD, (20140429), vol. 123, no. 24, doi:10.1182/blood-2014-01-552174, ISSN 0006-4971, pages 3750 - 3759, XP055201372 [AP] 1-14
SEARCH- BROWN J R ET AL, "Novel Treatments for Chronic Lymphocytic Leukemia and Moving Forward", AMERICAN SOCIETY OF CLINICAL ONCOLOGY EDUCATIONAL BOOK, (2014), vol. 34, doi:10.14694/EdBook_AM.2014.34.e317, ISSN 1548-8748, pages e317 - e325, XP055201368 [A] 1-14 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents